ESMO and EONS Announce Launch of PrEvCan

Get Permission

On September 9, the European Society for Medical Oncology (ESMO), together with the European Oncology Nursing Society (EONS), announced the launch of the Europe-wide “Cancer Prevention Across Europe” campaign (PrEvCan) aimed at reducing the burden of cancer. The announcement was made at the opening press conference of the ESMO Congress 2022.

According to reported data published by Dyba et al in the European Journal of Cancer from across Europe, in the year 2020, there were over 4 million new cancer diagnoses (excluding nonmelanoma skin cancers) and close to 2 million deaths from cancer in the region—which, on average, translates to a toll of 11,000 new cancer cases and 5,000 cancer deaths per day over the course of 12 months. By 2040, the number of new cancer cases in Europe will climb to an estimated 5.96 million, with mortality expected to rise to 2.91 million patients. 

“A worldwide increase in cancer cases of this magnitude imposes great physical, psychological, and financial burdens on individuals, their families, and communities,” said ESMO Public Policy Director Rosa Giuliani, MD. “There is an urgent need to intervene before cancer hits in order to reduce its burden. That means intensifying efforts in prevention, which the World Health Organization has already put forward as the most cost-effective long-term strategy for the control of cancer.”

More About PrEvCan

The PrEvCan campaign is initiated and led by EONS with ESMO as key partner, alongside the European Cancer Patients Coalition (ECPC) and more than 50 other international and national organizations. The campaign is based on the European Code Against Cancer (ECAC), which sets out 12 recommendations ranging from physical activity and dietary guidelines all the way to tobacco use and secondhand smoke. Over a period of 12 months starting from October 2022, each month will be dedicated to promoting one of these recommendations and highlighting the scientific evidence supporting it, with the dual objective of increasing awareness about how to prevent cancer among the general public and providing health-care professionals with a more comprehensive toolkit for communicating the importance of cancer prevention effectively.

Leadership Comments

“EONS firmly believes that it is vital to bring together nurses and medical oncologists at the front of cancer care,” said Johan de Munter, EONS President. He explained, “The 12 recommendations will be tailored for the purpose of targeting different audiences, especially hard-to-reach and disadvantaged demographic groups, as inequalities in access to screening measures and resources are known to adversely affect populations like the elderly, people with disabilities, and various underserved or underrepresented minorities.”

Lena Sharp, Project Lead for PrEvCan and Senior Advisor at EONS, added, “Nurses are the largest group of health-care workers and also one of the most trusted professional groups. Patients interact with us throughout their lifetime, which gives us an opportunity to intervene early on with advice and support in cancer prevention.”

“ECPC is glad to share this initiative with EONS and ESMO,” said Francesco De Lorenzo, ECPC President. “The coalition’s contribution, by sharing the campaign messages with more than 470 members across Europe, will help to strengthen and more widely disseminate the importance of healthy living. The PrEvCan campaign also represents an excellent opportunity for collaboration among cancer patient organizations, physicians, and oncology nursing societies in Europe, who are at the front line of cancer care,” De Lorenzo concluded. Kathi Apostolidis, ECPC Chair of the Scientific Committee and Past President, added that, “ECPC will continue its long-standing collaboration with EONS and ESMO in the PrEvCan campaign, aiming to reduce cancer risk and increase health and well-being.”

“One may wonder why the society representing medical oncologists, the doctors who treat patients with cancer, should deal with cancer prevention,” noted Dr. Giuliani, and explained, “Committing to cancer prevention is one way in which ESMO can contribute to helping people reduce their risk of developing cancer, and to support the overall sustainability of health-care systems. By reducing the number of cancer cases upfront as well as by increasing the rate of early diagnoses, where appropriate, we can substantially increase the number of healthy individuals and improve patient outcomes. At the same time, we can alleviate the strains on our health ecosystem in areas such as sourcing and access to medicines.”

In the context of the PrEvCan campaign, ESMO is contributing to closing the care gap through raising awareness of research-based prevention and serving as a dissemination network of education for oncologists, who have a crucial role to play by becoming knowledgeable and leading by example in this important field of action against cancer. 

“Prevention is the responsibility of each individual person, but it is also a team effort. We as oncologists, together with nurses, have the duty to promote all preventive initiatives, and we are called on to act as role models for our patients. We have to demonstrate that we not only work in cancer care, but also apply the oncology science to the daily lives of the general population, ourselves, and our patients,” said ESMO President Solange Peters, MD, PhD. 

The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.